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Introduction: Multidrug-resistant Enterobacteriaceae, particularly those resistant to gentamicin, have 
become one of the most important causes of nosocomial infections. 
Objective: We sought to investigate the presence of genes conferring resistance to aminoglycosides, 
specially to gentamicin, in Klebsiella pneumoniae and Escherichia coli multidrug-resistant strains 
isolated from different clinical materials among patients hospitalized in a university hospital in Rio de 
Janeiro, Brazil. 
Materials and methods: Ten colonization strains and 20 infection strains were evaluated during three 
decades (1980 to 2010) using selective media containing 8 µg/ml of gentamicin. Thirty strains were 
tested for antimicrobial susceptibility. Twenty two strains were subjected to plasmid DNA extraction and 
12 to hybridization assays using as probe a 1.9 kb plasmid DNA fragment from one of the K. pneumoniae 
strains isolated from faecal samples. This fragment was sequenced and assigned to the GQ422439 
GenBank record. PCR was also performed using oligonucleotides designed for aminoglycoside-
modifying enzymes.
Results: An accC2 acetylase, besides transposons and insertion sequences, were evidenced. Twenty-
four (80%) of the isolates were positive for the aacC2 gene in agreement with antibiotic susceptibility 
testing profiles, indicating the persistent presence of this gene throughout the three decades. We 
detected high molecular weight plasmids in 54,5% of the strains. Of the tested strains, 91% showed 
positive signal in the hybridization assays.
Conclusion: A gene codifying for one specific aminoglycoside-modifying enzyme was detected all 
throughout the three decades. Our data back the adoption of preventive measures, such as a more 
conscious use of antimicrobial agents in hospital environments, which can contribute to control the 
dissemination of microorganisms harboring resistance gene plasmids.
Key words: Enterobacteriaceae, infection; drug resistance, multiple, bacterial; enzymes, aminoglycoside, 
plasmids, acetylesterase.
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Detección y caracterización de enterobacterias resistentes a múltiples fármacos, portadoras 
del gen modificador de aminoglucósidos en un hospital universitario de Río de Janeiro, Brasil, 
durante tres décadas
Introducción. Las enterobacterias resistentes a la gentamicina se asocian frecuentemente a 
infecciones hospitalarias.
Objetivo. Verificar la presencia de los genes que confieren resistencia a los aminoglucósidos, 
específicamente a la gentamicina, en cepas de Klebsiella pneumoniae y Escherichia coli multirresistentes, 
obtenidas de pacientes internados en un hospital universitario de Río de Janeiro.  
Materiales y métodos. Se recolectaron y evaluaron 10 cepas de colonización y 20 de infección entre 
1980 y 2010, utilizando medios selectivos enriquecidos con gentamicina (8 µg/ml). Se obtuvieron 
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30 cepas en las que se determinó la resistencia a los antibióticos por medios fenotípicos. Veintidós 
muestras se sometieron a extracción de ADN plasmídico y se hicieron ensayos de hibridización 
en 12 de ellas, usando como sonda un fragmento de ADN plasmídico de 1,9 kb obtenido de una 
cepa de K. pneumoniae aislada de muestra fecal. Este fragmento fue secuenciado y correspondió 
al registro GQ422439 del GenBank. Se verificó la presencia de genes de enzimas modificadoras de 
aminoglucósidos mediante reacción en cadena de la polimerasa.
Resultados. En las cepas analizadas se evidenció la presencia de la acetilasa accC2, además de 
transposones y secuencias de inserción. Veinticuatro aislamientos (80 %) fueron positivos para el gen 
aacC2 en concordancia con los perfiles de sensibilidad a los antibióticos, lo que indicó su persistencia 
a lo largo de las tres décadas. Se detectaron plásmidos de alto peso molecular en 54,5 % de las cepas. 
El 91 % de las cepas analizadas mostró signos positivos en las pruebas de hibridación.
Conclusión. Se detectó la persistencia de un gen codificador de una enzima modificadora de 
aminoglucósidos a lo largo de las tres décadas. Los resultados indican que las medidas de prevención, 
tales como un uso más responsable de los agentes antimicrobianos en el ambiente hospitalario, 
pueden contribuir al control de la diseminación de microorganismos que albergan plásmidos de genes 
de resistencia.
Palabras clave: Enterobacteriacae, infección, farmacorresistencia bacteriana múltiple, enzimas, 
aminoglicósidos, plásmidos, acetilesterasa.
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In the last decades, multidrug-resistance of noso-
comial bacteria has been a concern for healthcare 
professionals around the world (1,2). Through 
gene acquisition or mutation, bacteria can become 
resistant to one or several antimicrobial drugs. 
Gene acquisition involving horizontal transfer 
is a more frequent resistance mechanism than 
mutations, especially among enterobacteria, and 
it involves plasmid, gene cassette and transposon 
participation (3).
Besides resistance genes, resistance plasmids 
can carry other genes that also contribute to the 
pathogenicity of microorganisms (4). The integrons 
can house several resistance genes in Gram-
negative bacteria. These genes may be found 
within resistance cassettes, and their different 
combinations can be generated by site-specific 
recombination (5). Transposons are also important 
in establishing bacterial resistance genes. The 
capacity of these mobile genetic elements ‘to 
circulate’ between plasmids and chromosomes 
is decisive for the dissemination of resistance-
encoding genes to antimicrobial agents as beta-
lactams and aminoglycosides (6,7).
Aminoglycosides are highly potent, broad-spectrum 
antibiotics, widely used for the treatment of life-
threatening infections. Resistance to these drugs oc-
curs through several mechanisms that can coexist in 
the same cell; nevertheless, these resistance is often 
due to enzymatic inactivation by acetyltransferases, 
nucleotidyltransferases (adenylyltransferases), and 
phosphotransferases. The accC2 gene is among 
the most frequently detected in strains of Enterobac-
teriaceae isolated from clinical samples (8). Many of 
these genes are associated with transposons, which 
help to the rapid dissemination of drug resistance 
across species boundaries (9).
In a previous study with Enterobacteriaceae strains 
of hospital origin we searched for genetic elements 
which express multidrug-resistance including resis-
tance to aminoglycosides (10). Probes were built 
to detect plasmids encoding these multidrug-
resistance traits. In the present work, we sought 
to investigate the presence of multidrug-resistant 
bacteria harboring aminoglycoside-resistance-
encoding genes, particularly to gentamicin, in 
clinical especimens from a university hospital, and 
the persistence of these genetic elements during 
three decades. In another study, Gonçalves (11) 
detected the aacC2 gene in strains of hospital origin, 
showing how the gene sequence was flanked by 
transposons and insertion sequences. 
Materials and methods
Isolated strains under study
We analyzed 30 Enterobacteriaceae strains (18 K. 
pneumoniae and 12 E. coli strains) from 28 patients 
interned in a 600-bed tertiary university hospital in 
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Rio de Janeiro, Brazil. Strains isolated from stool 
and urine samples of two of the patients were 
used. The strains were randomly selected from the 
multidrug-resistant Enterobacteriaceae (gentamicin-
resistant) collected in the university hospital. Both 
infection and colonization strains were isolated 
from samples recovered in different years: Five 
colonization and three infection strains recovered 
in 1980 and 1981; four colonization strains in 1990; 
seven infection and one colonization strains in 
2000, and 10 infection strains in 2010. The intestinal 
colonization strains, isolated in 1990 and 2000, 
were obtained from a primary streak in Eosin 
Methylene Blue Agar medium (EMB agar - Difco 
Laboratories, Detroit, MI) containing 8 µg/ml of 
gentamicin. The intestinal colonization strains and 
the infection strains recovered in 1980 and 1981 
were isolated and identified by the hospital bacte-
riology laboratory.
Antimicrobial susceptibility testing 
Antimicrobial susceptibility testing (AST) was per-
formed using the agar diffusion method as set by the 
Clinical Laboratories Standards Institute (CLSI) (12). 
Escherichia coli strain ATCC 25922 was used as 
control, and the following antimicrobial agents were 
tested (suppliers’ individual concentrations appear 
in brackets): sulfamethaxazole-trimethropim (St- 
23.75-1.25 µg), cephalotin (Cp- 30 µg), ceftazidime 
(Cz- 30 µg), cefoxitin (Fx- 30 µg), cefotaxime (Ct- 30 
µg), cephazoline (Cf- 30 µg), chloranphenicol (Ch- 
30 µg), ciprofloxacin (Ci- 5 µg), norfloxacin (Nr- 10 
µg), tetracycline (Tt- 30 µg) and ampicillin (Ap- 10 
µg). Aminoglycosides tested were: gentamicin (Gn- 
10 µg), amikacin (Ak- 30 µg), kanamycin (Kn- 30 
µg), tobramiycin (Tb- 10 µg), neomycin (Ne- 30 µg) 
and netilmycin (Nt- 30 µg).
Strains resistant to second and third generation 
cephalosporins in the AST were subjected to 
confirmatory tests for extended-spectrum beta-
lactamases (ESBL) production using the double-
disc synergy and the approximation tests as 
established by the CLSI (12).
Bacterial strains were grouped based on the results 
obtained in the susceptibility tests.
Plasmid DNA extraction and agarose gel 
electrophoresis in wild bacterial strains
Twenty two of 30 strains were randomly selected 
and subjected to DNA extraction and electropho-
resis (in 0.8% agarose gel) for plasmid detection 
following the Kado and Liu protocol (13). We used 
the E. coli R861 strain plasmid DNA as molecular 
weight marker. Electrophoresis gels were dyed with 
ethidium bromide solution (0.5 µg/ml), analyzed in 
ultraviolet transluminator and photographed with a 
Kodak EDAS 120 system.
B2d DNA fragment cloning
The 1.9 Kb B2d DNA fragment (GenBank accession 
number GQ422439) was obtained from Kp 401F10 
plasmid digestion with restriction enzymes. The 
plamid was obtained from the K. pneumoniae 20 
Kp strain isolated from the faeces of a surgical 
patient in the 80’s. B2d fragment sequencing was 
also performed to use it as a positive control for 
PCR and a probe for DNA hybridization. 
Automated DNA sequencing
B2d DNA fragment gene sequencing was done 
according to Otto, et al. (14). Sequences were ana-
lyzed and compared using the BioEdit Sequence 
Alignment Editor software (15). 
PCR conditions
The thermal cycling conditions were performed in 
a Cetus model 480 thermal cycler (Perkin-Elmer, 
Norwalk, CT). The primers used were: aacC2 gene 
yielding a 237 bp product (5’-ACT GTG ATG GGA 
TAC GCG TC-3’ and 5’-CTC CGT CAG CGT TTC 
AGC TA-3’); aadB gene yelding a 320 bp product 
(5’-GAG CGA AAT CTG CCG CTC TGG-3’ and 5’- 
CTG TTA CAA CGG ACT GGC CGC-3’), and aacC3 
gene yielding a 815 bp product (5’-AAA CTG GTG 
GCA ATA GAA GGA T-3’ and 5’- CTA TCC GTA TGA 
CGC TGA GTC3’), according to van de Klundert 
and Vliengenthart’s protocol (16). PCR assays 
were performed in a 50 µl total volume adding the 
following components to the reaction tubes: 1 µL of 
target DNA (obtained from dilutions of colonies in 
50 µL of 10 mM Tris, 1 mM EDTA -pH 8.0), 1.5 mM 
MgCl2, 0.2 mM of dNTP mixture (dATP, dTTP, dCTP 
and dGTP), 20 pmol of each primer, 1x PCR buffer, 
and 1.25U of Taq DNA Polymerase. The amplified 
products were subjected to electrophoresis in a 2% 
agarose gel.
DNA hybridization assays 
For the DNA hybridization assays we used Thomas 
protocol (17): After electrophoresis in agarose gel, 
DNA extracted from K. pneumoniae and E. coli wild 
strains was transferred to a nylon membrane by 
capillarity system. The 1.9 Kb B2d DNA fragment 
was labeled with α[dATP] P32 through random 
primed labeling (Gibco®, Life Technologies, US) 
and used as probe according to Feinberg and 
Vogelstein’s method (18).
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Results
Identifying the antimicrobial susceptibility 
profiles
Antimicrobial resistance profiles were determined 
based on the results of the AST performed with 
aminoglycosides and other drugs. K. pneumoniae 
and E. coli strains AST for aminoglycosides indicated 
a high frequency of resistance to Gn, Kn and Tb 
(21 strains: 70%). Regarding the other antimicrobial 
agents, AST indicated a high frequency of resistance 
to Cp, Ch, Tt and Ap (17 strains: 57%) (table 1).
Fifteen strains were subjected to ESBL-production 
confirmatory tests and seven (46.7%) presented 
the ESBL phenotype. ESBL positive strains dis-
tribution was as follows: 1 (25%) from strains 
isolated in 1990; 1 (12.5%) from strains isolated 
in 2000, and 5 (50%) from strains isolated in 2010 
(table 1). None of the strains isolated in 1980 or 
1981 were ESBL positive. However, one strain 
(12.5%) isolated in this latter period, as well as 
one strain (12.5%) isolated in 2000, showed 
resistance to the third generation cephalosporin 
Cz (table 1). 
Table 1. Characterization of resistance profiles to antimicrobials, and enzymatic and hybridization signals of E. coli and K. pneumoniae 
strains isolated from different material collected from hospitalized patients in a university hospital in Rio de Janeiro 
Strains Mat Origin Antimicrobial profile CBL aacC2 HS
1980/1981
18 Kp
20 Kp
22 Kp
35 Kp
36 Kp
39 Ec
40 Ec
41 Kp
1990
9 Ec
10 Ec
11 Ec
38 Kp
2000
1 Kp
2 Kp
5 Kp
13 Kp
17 Kp
25 Ec
31 Kp
42 Ec
2010
43 Ec
44 Ec
45 Ec
46 Ec
47 Kp
48 Ec
49 Kp
2010
50 Kp
51 Kp
52 Kp
Fc
Fc
Fc
Fc
Ur
Fc
Ur
Fc
Fc
Fc
Fc
Fc
Bl
DS
Bl
DS
Bl
Ur
Fc
Ur
Ur
Ur
DS
Ur
DS
Ur
Bl
Ur
PF
TCT
GS
GS
GS
IE
O
IE
NS
IE
N
N
N
N
GICU
GICU
NICU
VS
NS
Nph
C
AU
A
A
TS
A
GICU
A
N
DIP
Nph
Nph
Gn/Kn/Nt/Cp/Cf/Ch/Tt/Ap
Gn/Kn/Tb/Ne/St/Cp/Fx/Ch/Tt/Ap
Gn/Kn/Tb/Ne/Nt/St/Cp/Fx/Ch/Tt/Ap
Gn/Ak/Kn/Tb/Nt/Cp/Ch/Tt/Ap
Gn/Cp/Cz/Ch/Ap
Gn/Ch/Tt/Ap
Gn
Gn/Kn/Tt
Gn/Ak/Kn/Tb/Nt/St/Cp/Ch/Tt/Ap
Gn/Kn/Tb/Nt/Cf/Tt/Ap
Gn/Ak/Kn/Tb/Nt/Cp/Cf/Ct/Ch/Tt/Ap
Gn/Ak/Kn/Tb/St/Cp/Ch/Tt/Ap
Gn/Kn/Tb/Nt/St/Cp/Ch/Tt/Ap
Gn/Kn/Tb/Ne/Nt/St/Cp/Fx/Cz/Ch/Tt/Ap
Gn/Ak/Kn/Tb/Ne/Nt/Cp/Ch/Tt/Ap
Gn/Kn/Tb/St/Cp/Cz/Ch/Tt/Ap
Gn/Ak/Kn/Tb/Nt/St/Ch/Tt/Ap
Gn/Ak/Kn/Nt/St/Cp/Fx/Ch/Tt/Ap
Gn/Tb/Fx/Ch/Tt/Ap
Gn/Ak/Kn/Tb/Nt/St/Cp/Ch/Tt/Ap
Gn/Tb/St/Ci/Nr/Tt/Ap
Gn/Cp/Cf/Nr/Ch/Tt
Gn/Kn/Tb/St/Cp/Cf/Ct/Ci/Nr/Ch/Ap
Gn/Kn/Tb/St/Cp/Cf/Ct/Ch/Tt/Ap
Gn/Kn/Tb/Cp/Cf/Fx/Ct/Ap
Gn/Kn/Tb/Cp/Cf/Fx/Ci/Nr/Tt/Ap
Gn/St/Cp/Cf/Ct/Cz/Tt/Ap
Gn/Kn/Tb/Cp/Cf/Ct/Ci/Nr/Tt/Ap
Gn/Kn/Tb/St/Cp/Cf/Ct/Ci/Nr/Ch/Tt/Ap
Gn/Tb/St/Cp/Cf/Cf/Ct/Ci/Nr/Ch/Tt/Ap
-
Neg
Neg
-
Neg
-
-
-
-
-
Pos
-
-
Pos
-
Neg
-
Neg
-
-
-
-
Pos
Pos
Pos
Neg
Pos
Pos
Neg
Neg
Pos
Pos
Pos
Pos
Neg
Pos
Pos
Neg
Pos
Neg
Pos
Pos
Pos
Pos
Pos
Neg
Pos
Pos
Neg
Pos
Pos
Neg
Neg
Pos
Neg
Pos
Pos
Pos
Pos
Pos
Pos
Pos
Pos
Pos
-
-
-
-
Pos
Neg
Pos
Pos
Pos
Pos
Pos
Pos
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Kp: Klebsiella pneumoniae; Ec: Escherichia coli; Mat: Material; Fc: Faeces; Ur: Urine; Bl: Blood; DS: Different secretions; PF: Peritoneal fluid; TCT: 
Tenckhoff catheter tip; GS: General surgery; IE: Infantile emergency; O: Obstetrics; NS: Neurosurgery; N: Nursery; GICU: General intensive care unit; 
NICU: Neonatal intensive care unit; VS: Vascular surgery; Nph: Nephrology; C: Cardiology; AU: Adolescent unit; A: Ambulatory; TS: Thoracic surgery; 
DIP: Infectious diseases unit; Gn: Gentamicin; Ak: Amikacin; Kn: Kanamycin; Tb: Tobramycin; Ne: Neomycin; Nt: Netilmycin; St: Sulfamethaxazole-
trimethropim; Cp: Cephalotin; Cf: Cephazoline; Fx: Cefoxitin; Ct: Cefotaxime; Cz: Ceftazidime; Ci: Ciprofloxacin; Nr: Norfloxacin; Ch: Chloranphenicol; 
Tt: Tetracycline; Ap: Ampicillin; CBL: Confirmatory test to ESBL; Neg: Negative result; Pos: Positive result; HS: Hybridization signal; -: Data not 
observed for this strain
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Plasmid profile of strains
Out of the 22 strains randomly selected, 14 corres-
ponded to K. pneumoniae and eigth to E. coli. 
They were subjected to plasmid DNA extractions 
with the following results: Nine strains (41%) had 
plasmids with molecular weights of 147 kb or more, 
and plasmids of around 7 kb (figure 1). Strains 9 
Ec, 10 Ec and 11 Ec isolated in 1990 had similar 
eletrophoretic patterns, as well as strains 18 Kp, 20 
Kp and 22 Kp isolated in 1980 and 1981, while only 
strain 38 Kp from 1990 and strains 2 Kp, 5 Kp and 
13 Kp from 2000 showed such similarity.
Analysis of DNA sequences 
DNA sequencing was performed for the B2d DNA 
fragment originated from plasmid 20 Kp. The 1.9 kb 
repeat sequence obtained indicated the presence 
of DNA sequences homologous to the aacC2 gene 
or to the aminoglycoside-(3)-N-acetyltransferase 
(AAC (3) II). The BLASTTM analysis of the B2d 
fragment allowed us to identify a subset of repeats 
that showed over 90% of overall identity and E 
values <0.05 when compared to other GenBank 
records, mostly related to acetyltransferases, 
insertion sequences and transposons found in 
Gram-negative bacteria (figure 2). The most signi-
ficant sequences aligned to the B2d fragment 
were: Salmonella enterica subsp. enterica serovar 
Choleraesuis TnpA_rve (GI: 161867979); Esche-
richia coli IAI39 transposase, IS26 (GI: 218700153); 
Acinetobacter baumannii AB0057 transposase IS26 
(GI: 213155651); Escherichia coli AAC(3)-II (GI: 
41056930), and Citrobacter freundii aminoglycoside 
acetyltransferase (GI: 27383509).
Detection of sequences coding for 
aminoglycoside modifying enzymes
Amplification products indicated the presence of the 
aacC2 gene (GenBank access number X51534) 
in 13 (72,2%) K. pneumoniae strains and nine 
(75%) E. coli strains (table 1). We did not detect 
amplification for the other genes under study.
Hybridization profiles
Plasmid DNA was extracted from 12 strains which 
were subsequently subjected to DNA hybridization 
assays using the B2d fragment as probe (data 
not shown). Positive signals were obtained for 11 
(91.7%) of the 12 strains tested (table 1). Regarding 
the extracts of Kp 18 and Kp 38 strains isolated in 
1981 and 1990, respectively, hybridization signals 
were detected in the chromosome. Strain Kp 5, 
isolated in 2000, and strain Ec 11, isolated in 1990, 
showed more than one band, indicating that the 
gene sequences identified in the B2d fragment 
were present in several regions of the bacterial 
genome. In the other strains with more than one 
plasmid, the hybridization signal was detected in 
just one of the plasmid bands.
Discussion
To characterize the resistance profile of the isolated 
strains, we selected different classes of antimicrobial 
agents: those which have been used for a long time, 
as well as some classes introduced more recently 
in therapeutics, such as beta-lactam antibiotics and 
aminoglycosides, important antimicrobial drugs used 
in hospital environments to which microorganisms 
have increasingly become resistant (19,20).
ESBL-producing Gram-negative bacteria have been 
detected since the 1980s as important causes of 
nosocomial infections (21). After the introduction of 
expanded-spectrum cephalosporins, K. pneumoniae 
and E. coli resistant strains emerged in certain 
areas of the world (22). In fact, this study detected 
multidrug-resistant, aminoglycoside resistant and 
ESBL-producing strains in the different decades. 
Among those isolated in the 80’s, despite the 
absence of ESBL-producing strains, we detected 
resistance to third generation cephalosporins.
Aminoglycosides susceptibility profiles in strains 
isolated between September 1980 and January 
1981 were similar to those in strains isolated in 
1990, 2000 and 2010. TSA results agreed with 
Figure 1. Ethidium bromide-stained agarose gel electrophoresis 
containing E. coli and K. pneumoniae plasmid DNA extracts 
isolated from different materials for plasmid detection according 
to the Kado and Liu protocol (13). Running conditions: 6.0 V/cm 
in 0.8% agarose; 861- molecular weight marker; R23- E. coli K 
12 negative control; K- K. pneumoniae; E- E.coli
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those described in the literature for the acetylase 
identified as AAC(3)-II (Gen/Tob/Net) in most of the 
strains (8). Small changes in DNA sequences in 
genes throughout the replication processes, and/
or acquired genes, may have resulted in these 
phenotypical differences.
Several environmental and nosocomial bacteria 
can contain transferable plasmids that carry genes 
expressing several traits, one of which is multidrug-
resistance to antimicrobial drugs (23-25). In fact, 
we found plasmids with molecular weights varying 
between 147 kb or more and 7 kb or less in 
multidrug-resistant strains isolated from especi-
mens of patients hospitalized in different units and 
in different decades. These genetic elements can 
be transferred from a microorganism to another 
in vivo, vertically or horizontally, contributing to 
worsen hospital infections (3).
The similarity of plasmid profiles in strains isolated 
in different decades indicates the persistence of 
bacterial clones and/or of specific plasmids. Well es-
tablished populations of bacterial clones can extend 
their resistance phenotypes by acquiring genetic ele-
ments (plasmids, integrons and transposons), facili-
tating co-selection processes under different levels 
of pressure and favoring the permanence of these 
microorganisms and their genetic constituents in the 
environment (26). The possibility of co-transmission 
may not only contribute to increase resistance 
markers, but also confer an evolutionary benefit to 
these strains, leading to selection in an environment 
with persistent antibiotic pressure by beta-lactams, 
aminoglycosides and quinolones (3,24,27).
The B2d clone sequencing showed that, besides 
sequences compatible with the aacC2 gene (ACC 
(3)–II), there are other sequences compatible with 
transposons, insertion sequences and plasmid-
mediated resistance to macrolides and other anti-
microbial drugs. With respect to the presence of 
more than one hybridization signal observed in 
two strains (Kp 5 and Ec 11), we considered the 
possibility of different insertion events occurring 
throughout several generations of bacteria, which 
may have involved different plasmids in the same 
bacterial cell. We observed how these DNA 
sequences can determine DNA insertions in 
one or more genomic sites, originating resistant 
strains, irrespective of the presence of original 
mobile genetic elements. When we compared 
sequence frames with those already described 
in the GenBank, we were able to detect identity 
regions in microorganisms from different species, 
indicating the possibility of horizontal resistance 
gene transfer involving plasmids, transposons and 
insertion sequences. When analyzing 160 strains 
of gentamicin-resistant E. coli isolated from human 
and animal samples, Ho, et al. (28), identified the 
aacC2 gene in 81.3% of them, thus confirming 
this possibility.
Based on the results obtained with the hybridiza-
tion and PCR assays, it can be said that genetic 
elements housing multidrug-resistance encoding 
sequences presumably remain in circulation among 
microorganisms in hospital environments for long 
periods of time, and that these microorganisms 
may colonize and cause infections in hospitalized 
patients. Isolated strains were tested not only for 
the same period as the Kp 20 strain from which the 
fragment used as probe was extracted (1980/81), 
but in those isolated 10, 20 and even 30 years 
later (1990, 2000 and 2010, respectively). Selective 
pressure can be acting in favor of the persist-
ence of several genes grouped in one operon 
Figure 2. Linear map of the partial sequence of the B2d DNA fragment originated from the plasmid 20 Kp examined in this study 
showing sequences compatible with the aacC2 gene (ACC (3)–II), as well as transposons, insertion sequences and plasmids of 
resistance to macrolydes and other antimicrobial drugs
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that, otherwise, could be eliminated. Besides, it is 
important to note that gene cassettes can contain 
many of the resistance genes expressed in Gram-
negative bacteria (6).
The Kp 20 strain was originally isolated from faeces 
of a patient admitted in a general surgery ward. 
It is known that intestinal microbiota components 
are affected during antimicrobial therapeutics 
decreasing their number, and favoring prolifera-
tion of opportunistic microorganisms which can 
disseminate and cause infections (29). The 
human intestine provides an important reservoir 
for multidrug-resistant Gram-negative bacteria, 
including Enterobacteriaceae species involved 
in infectious processes both in community and 
nosocomial environments, and the use of anti-
microbial agents is one of the important factors for 
the selection of multidrug-resistant microorganisms 
(20,30).
We want to emphasize the importance of reducing 
hospital stays, as well as of a more discerning and 
conscious use of antimicrobial agents in inpatient 
and outpatient hospital environments, and of edu-
cational programs aimed at updating healthcare 
professionals, especially on the importance of 
adequate hand washing before and after patient 
care, to name only some of the measures to control 
the persistent dissemination of microorganisms 
with resistance genes and plasmids. 
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